Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays revision v3.6.5, replacing the previous revision v3.6.4. This indicates a minor site update or patch to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a small maintenance update with no changes to the study details or underlying content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's version label changed from v3.6.2 to v3.6.3, signaling a new revision of the page content. This update reflects a deployment of a newer page version and does not modify the core study information visible to users.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer site version.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study page now shows recruitment is closed. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Interventions label formatting along with the page revision tag were updated to v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page shows a new revision tag v3.5.5, representing a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.